Interventional therapies for relief of obstruction in hypertrophic cardiomyopathy: discussion and proposed clinical

Srihari S Naidu1, Jason Jacobson1, Sei Iwai1

  • 1a Division of Cardiology, Department of Medicine , Westchester Medical Center , Valhalla , NY , USA.

Insights

Hypertrophic cardiomyopathy (HCM) affects 1 in 300 individuals and presents with diverse symptoms and anatomies. Interventional and surgical options offer improving outcomes for obstruction relief in HCM patients.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is now recognized as more prevalent, affecting up to 1 in 300 individuals across all demographics.
  • Increased awareness, advanced imaging, and specialized centers lead to earlier and more frequent clinical presentations of HCM.
  • Patients present with varied symptoms, including heart failure, dyspnea, angina, syncope, and edema, and distinct anatomical variations like mid-ventricular obstruction or apical disease.

Purpose of the Study:

  • To review interventional approaches for relieving obstruction in hypertrophic cardiomyopathy (HCM).
  • To present a clinical algorithm for selecting between interventional and surgical approaches for HCM treatment.
  • To highlight the evolving landscape of invasive treatment options for HCM.

Main Methods:

  • Review of current interventional and surgical techniques for HCM obstruction relief.
  • Analysis of clinical data and outcomes associated with different treatment modalities.
  • Development and presentation of a decision-making algorithm for treatment selection.

Main Results:

  • Both percutaneous and surgical interventions are available for the spectrum of HCM severity and anatomy.
  • Treatment techniques and outcomes continue to improve with evolving experience.
  • Advances allow for targeted and individualized treatment strategies for most HCM patients.

Conclusions:

  • Interventional and surgical options provide effective treatment for hypertrophic cardiomyopathy (HCM).
  • Personalized treatment algorithms can guide optimal selection between interventional and surgical approaches.
  • Ongoing advancements promise further improvements in managing HCM obstruction and patient outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
593
Nursing Interventions I: Taxonomy of Nursing Interventions01:03

Nursing Interventions I: Taxonomy of Nursing Interventions

Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
4.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.4K